Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Cancer Research|August 6, 2013
Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cellsAlexander Sio, Manreet K Chehal, Kevin Tsai, et al.
Plos One|January 5, 2011
Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokinesEric Tran, Julie S Nielsen, Darin A Wick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for ImmunotherapyCharlotte S Lo, Sanaz Sanii, David R Kroeger, et al.
Neuro-Oncology Advances|October 4, 2021
Avelumab in newly diagnosed glioblastomaFrancois H Jacques, Garth Nicholas, Ian A J Lorimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2021
Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian CancerCéline M Laumont, Maartje C A Wouters, Julian Smazynski, et al.
Science Advances|May 15, 2024
N-MYC impairs innate immune signaling in high-grade serous ovarian carcinomaAlex Miranda, Swetansu Pattnaik, Phineas T Hamilton, et al.
Cancer Letters|January 24, 2026
Copper ionophores drive divergent responses to immune checkpoint inhibition across colorectal tumor modelsDevon Heroux, Xu Xin Sun, Sijie Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
Oncoimmunology|August 13, 2014
Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapyLisa Ds Johnson, Nancy J Nesslinger, Paul A Blood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancerDarin A Wick, John R Webb, Julie S Nielsen, et al.
Pageof 14